Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies
- PMID: 8806551
- DOI: 10.1006/viro.1996.0466
Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies
Abstract
A panel of 24 monoclonal antibodies (MAbs) was generated against human papillomavirus (HPV) types 16 and 18 L1 virus-like particles (VLPs). The MAbs were screened for reactivity to a variety of VLPs prepared from HPV-6, -11, -16, -18, -31, -33, -35, and -45, cottontail rabbit papillomavirus, bovine papillomavirus type 1, and a set of 35 overlapping 20-amino-acid peptides spanning the entire HPV-16 L1 gene. Type-specific linear and conformational surface epitopes were detected as well as several cross-reactive linear epitopes that showed various levels of cross-reactivity between different genital HPV and animal papillomavirus L1s. Most of the linear epitopes were mapped using synthetic peptides, and the epitopes were identified as being either surface or buried within the VLP as defined by the pattern of reactivity in ELISA using intact and disrupted VLP antigen. These MAbs may be useful reagents to help define neutralizing epitopes of HPV-16 and -18 when infectivity assays become available, and to define the regions of L1 that are exposed on the surface or buried within the assembled capsid.
Similar articles
-
Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.Virology. 1996 Oct 15;224(2):477-86. doi: 10.1006/viro.1996.0554. Virology. 1996. PMID: 8874508
-
Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.Virology. 2001 Dec 20;291(2):324-34. doi: 10.1006/viro.2001.1220. Virology. 2001. PMID: 11878901
-
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses.J Virol. 2002 Jul;76(13):6480-6. doi: 10.1128/jvi.76.13.6480-6486.2002. J Virol. 2002. PMID: 12050360 Free PMC article.
-
Chapter 12: Prophylactic HPV vaccines: underlying mechanisms.Vaccine. 2006 Aug 31;24 Suppl 3:S3/106-13. doi: 10.1016/j.vaccine.2006.05.110. Epub 2006 Jun 23. Vaccine. 2006. PMID: 16949996 Review.
-
Functional assessment and structural basis of antibody binding to human papillomavirus capsid.Rev Med Virol. 2016 Mar;26(2):115-28. doi: 10.1002/rmv.1867. Epub 2015 Dec 17. Rev Med Virol. 2016. PMID: 26676802 Review.
Cited by
-
Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.Virol J. 2012 Feb 22;9:52. doi: 10.1186/1743-422X-9-52. Virol J. 2012. PMID: 22356831 Free PMC article.
-
Comparisons of VLP-Based ELISA, Neutralization Assays with Native HPV, and Neutralization Assays with PsV in Detecting HPV Antibody Responses in HIV-Infected Women.J AIDS Clin Res. 2015 Mar;6(3):433. doi: 10.4172/2155-6113.1000433. J AIDS Clin Res. 2015. PMID: 26085957 Free PMC article.
-
Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay.Clin Diagn Lab Immunol. 2003 Jan;10(1):108-15. doi: 10.1128/cdli.10.1.108-115.2003. Clin Diagn Lab Immunol. 2003. PMID: 12522048 Free PMC article.
-
Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection.J Virol. 2019 Jul 17;93(15):e00454-19. doi: 10.1128/JVI.00454-19. Print 2019 Aug 1. J Virol. 2019. PMID: 31092566 Free PMC article.
-
Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates.J Virol. 1997 Sep;71(9):7068-72. doi: 10.1128/JVI.71.9.7068-7072.1997. J Virol. 1997. PMID: 9261437 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases